Takara Bio Inc.

    Takara Bio Inc.

    TTSE:4974
    1,144.00
    JPY
    +1.00
    (+0.09%)
    305.72P/E
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    2026 Y
    TTM
    Revenue per Share
    203.27
    215.66
    246.89
    243.95
    268.34
    297.65
    287.05
    382.73
    562.21
    648.94
    361.56
    374.24
    - -
    202.66
    Basic EPS, GAAP
    12.5
    8
    11.08
    11.23
    19.39
    30.37
    31.72
    79.28
    164.84
    132.97
    12.3
    8.65
    - -
    3.29
    Free Cash Flow per Basic Share
    -29.44
    -11.07
    5.37
    17.17
    19.46
    -2.48
    18.99
    42.34
    -46.12
    257.57
    -92.76
    -36.84
    - -
    -15.1
    Dividend per Share
    1.05
    1.19
    1.49
    1.79
    3.99
    4.49
    6.98
    7.99
    15.97
    32.95
    41.99
    17.02
    - -
    0.04
    Book Value per Share
    473.91
    494.45
    498.32
    497.3
    513.64
    531.56
    552.2
    616.03
    796.17
    931.91
    925.98
    959.16
    - -
    961.82
    Tangible Book Value per Share
    452.42
    469.56
    475.94
    478.19
    396.02
    426.69
    457.91
    538.19
    720.11
    856.78
    859.32
    892.97
    - -
    890.74
    Basic Weighted Avg Shares
    118
    120
    120
    120
    120
    120
    120
    120
    120
    120
    120
    120
    120
    120
    Sales/Revenue/Turnover
    23,905
    25,969
    29,729
    29,375
    32,312
    35,841
    34,565
    46,086
    67,699
    78,142
    43,505
    45,039
    - -
    24,389
    Operating Margin (%)
    8.19
    8.88
    8.98
    10.91
    11.01
    15.25
    18.16
    30.28
    42.69
    26.29
    6.9
    5.03
    - -
    6.53
    Depreciation Expense
    1,467
    1,672
    2,067
    2,049
    3,217
    3,375
    3,530
    3,786
    4,149
    4,735
    5,021
    4,481
    - -
    2,532
    Net Income, GAAP
    1,470
    963
    1,334
    1,352
    2,335
    3,657
    3,819
    9,547
    19,849
    16,012
    1,480
    1,041
    - -
    396
    Effective Tax Rate (%)
    33.23
    61.31
    53.87
    51.66
    30.44
    23.82
    29.47
    29.3
    27.69
    24.39
    47.07
    45.57
    - -
    67.51
    Profit Margin (%)
    6.15
    3.71
    4.49
    4.6
    7.23
    10.2
    11.05
    20.72
    29.32
    20.49
    3.4
    2.31
    - -
    1.62
    Working Capital
    37,445
    31,008
    36,728
    37,939
    28,771
    29,258
    32,139
    35,924
    50,761
    63,194
    55,591
    50,548
    - -
    57,063
    LT Debt
    225
    178
    130
    82
    - -
    - -
    986
    1,003
    910
    821
    788
    908
    - -
    - -
    Total Equity
    57,124
    59,640
    60,107
    59,983
    61,956
    64,093
    66,589
    74,300
    96,062
    112,452
    111,782
    115,846
    - -
    116,153
    Return on Invested Capital (%)
    2.62
    1.51
    2.04
    2.55
    4.03
    6.56
    6.66
    13.42
    23.07
    14.34
    1.4
    1.07
    - -
    0.45
    Return on Capital (%)
    2.99
    1.66
    2.21
    2.24
    3.84
    5.78
    5.79
    13.31
    22.96
    15.19
    1.29
    0.88
    - -
    0.34
    Return on Common Equity (%)
    2.99
    1.65
    2.23
    2.26
    3.84
    5.81
    5.85
    13.57
    23.34
    15.39
    1.32
    0.92
    - -
    0.35

    Capital Structure

    JPY

    •

    in mil. unless spec.
    Mar'24
    Jun'25
    Sep'25
    ST Debt
    180
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    788
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    120
    120
    120
    Market Capitalization
    116,803
    132,939
    121,138

    Working Capital

    JPY

    •

    in mil. unless spec.
    Mar'24
    Jun'25
    Sep'25
    Total Current Assets
    62,759
    - -
    63,771
    Cash, Cash Equivalents & STI
    35,416
    - -
    39,957
    Accounts Receivable, Net
    10,214
    - -
    9,230
    Inventories
    11,850
    - -
    12,798
    Total Current Liabilities
    7,168
    - -
    6,708
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    180
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    JPY

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    - -
    Free Cash Flow
    - -
    - -
    - -
    Net Income, GAAP
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    9,176
    9,940
    10,618
    13,771
    43,505
    2025
    - -
    - -
    - -
    - -
    45,039
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    2.65
    - -
    - -
    - -
    12.3
    2025
    - -
    - -
    - -
    - -
    8.65
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    40.46
    - -
    - -
    - -
    41.99
    2025
    - -
    - -
    - -
    - -
    17.02
    2026
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business